Firestone Capital Management Bristol Myers Squibb CO Transaction History

Firestone Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $290 - $347	6 Added 0.15%	3,903 $200,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $28,945 - $32,365	500 Added 14.72%	3,897 $226,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $22,998 - $26,085	350 Added 11.49%	3,397 $235,000
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $684 - $810	-10 Reduced 0.33%	3,047 $219,000
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $187,944 - $225,362	3,057 New	3,057 $223,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $163,946 - $191,123	-3,057 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $593 - $667	10 Added 0.33%	3,057 $193,000
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $32,035 - $41,787	-651 Reduced 17.6%	3,047 $196,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $181,978 - $237,374	3,698 New	3,698 $196,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Firestone Capital Management with notifications on news.